AXA Capital Global Equity Inst I USD Acc |
Performance History | 31/10/2024 |
Growth of 1,000 (EUR) |
Fund | - | - | - | - | 16.6 | |
+/-Cat | - | - | - | - | 2.4 | |
+/-Idx | - | - | - | - | -3.3 | |
Category: Global Large-Cap Growth Equity | ||||||
Benchmarks: Morningstar Gbl Growth TME ... |
Key Stats | ||
NAV 20/11/2024 | USD 130.82 | |
Day Change | 0.53% | |
Morningstar Category™ | Global Large-Cap Growth Equity | |
ISIN | IE000892VKO6 | |
Fund Size (Mil) 20/11/2024 | JPY 684043.34 | |
Share Class Size (Mil) 20/11/2024 | JPY 2245.94 | |
Max Initial Charge | - | |
Ongoing Charge 01/08/2024 | 0.78% |
Investment Objective: AXA Capital Global Equity Inst I USD Acc |
The investment objective of the find is to provide investors with long-term capital growth from a diversified and actively managed portfolio of securities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 19/10/2023 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
- | Morningstar Gbl Growth TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for AXA Capital Global Equity Inst I USD Acc | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Meta Platforms Inc Class A | Communication Services | 3.87 |
Microsoft Corp | Technology | 3.42 |
Taiwan Semiconductor Manufacturi... | Technology | 3.24 |
Broadcom Inc | Technology | 2.83 |
Novo Nordisk AS Class B | Healthcare | 2.44 |
Increase Decrease New since last portfolio | ||
AXA Capital Global Equity Inst I USD Acc |